

Typhoid fever is still a major problem with a reported global burden estimate of 26.9 million cases in 2010 with a case fatality rate of 1%. The Philippines had 2,025 cases of typhoid and paratyphoid fever in 2010, a marked decrease from the 2003 figure of 16,444 cases. Morbidity is 30.5/100,000 population and mortality is 1.7/100,000 population.
To help clinicians in the diagnosis and management typhoid fever, the Philippine Society for Microbiology and Infectious Diseases (PSMID) formulated this clinical practice guidelines to:
DOWNLOAD the Clinical Practice Guidelines for Typhoid Fever in Adults 2017 here.
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.